{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:26:00Z","timestamp":1790400360716,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.cgh.2012.06.016","type":"journal-article","created":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T01:45:53Z","timestamp":1340415953000},"page":"1021-1027.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Effects of Cancer Treatment on Inflammatory Bowel Disease Remission and Reactivation"],"prefix":"10.1016","volume":"10","author":[{"given":"Jordan E.","family":"Axelrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharyle A.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin N.","family":"Ananthakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Yajnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2012.06.016_bib1","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.06.016_bib2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2012.06.016_bib3","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2005.12.035","article-title":"Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis","volume":"130","author":"Rutter","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.06.016_bib4","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2036.2006.02854.x","article-title":"Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease","volume":"23","author":"Canavan","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2012.06.016_bib5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/01.mib.0000179211.03650.b6","article-title":"Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo","volume":"11","author":"Palascak-Juif","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.06.016_bib6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/annonc\/mdn595","article-title":"Cancer risks in Crohn disease patients","volume":"20","author":"Hemminki","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cgh.2012.06.016_bib7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10350-006-0848-z","article-title":"The risk of cancer in patients with Crohn's disease","volume":"50","author":"von Roon","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2012.06.016_bib8","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/ajg.2009.760","article-title":"Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies","volume":"105","author":"Pedersen","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.06.016_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0300-483X(02)00612-1","article-title":"Immunosuppressive drugs and cancer","volume":"185","author":"Vial","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.cgh.2012.06.016_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00126334-200304150-00010","article-title":"Immune deficiency and risk for malignancy among persons with AIDS","volume":"32","author":"Mbulaiteye","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cgh.2012.06.016_bib11","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2012.06.016_bib12","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/ajg.2009.745","article-title":"Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case\u2013control study","volume":"105","author":"Armstrong","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.06.016_bib13","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cgh.2009.01.004","article-title":"Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis","volume":"7","author":"Siegel","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.06.016_bib14","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/ibd.21484","article-title":"Nonmelanoma skin cancer in inflammatory bowel disease: a review","volume":"17","author":"Long","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2012.06.016_bib15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2012.06.016_bib16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00012","article-title":"NIH conference","volume":"128","author":"Langford","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2012.06.016_bib17","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1053\/j.gastro.2005.12.019","article-title":"Predictors of Crohn's disease","volume":"130","author":"Beaugerie","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.06.016_bib18","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/gut.2005.084061","article-title":"Phenotype at diagnosis predicts recurrence rates in Crohn's disease","volume":"55","author":"Wolters","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2012.06.016_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.crohns.2011.06.006","article-title":"Predictors for subsequent need for immunosuppressive therapy in early Crohn's disease","volume":"6","author":"Wenger","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2012.06.016_bib20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/oxfordjournals.aje.a117246","article-title":"Increased risk of inflammatory bowel disease associated with oral contraceptive use","volume":"140","author":"Boyko","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cgh.2012.06.016_bib21","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/j.1572-0241.2008.02064.x","article-title":"The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis","volume":"103","author":"Cornish","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.06.016_bib22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1572-0241.2007.01700.x","article-title":"Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease","volume":"103","author":"Kane","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2012.06.016_bib23","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1042\/BST0341114","article-title":"New developments in oestrogen signalling in colonic epithelium","volume":"34","author":"Wada-Hiraike","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.cgh.2012.06.016_bib24","doi-asserted-by":"crossref","first-page":"G621","DOI":"10.1152\/ajpgi.00274.2010","article-title":"Estrogen receptor-\u03b2 signaling modulates epithelial barrier function","volume":"300","author":"Looijer-van Langen","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cgh.2012.06.016_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/B:IFLA.0000006703.53427.da","article-title":"Estradiol treatment ameliorates acetic acid-induced gastric and colonic injuries in rats","volume":"27","author":"G\u00fcnal","year":"2003","journal-title":"Inflammation"},{"key":"10.1016\/j.cgh.2012.06.016_bib26","doi-asserted-by":"crossref","first-page":"G118","DOI":"10.1152\/ajpgi.00024.2003","article-title":"Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease","volume":"286","author":"Harnish","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cgh.2012.06.016_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/me.2005-0459","article-title":"Estrogen receptor-beta: recent lessons from in vivo studies","volume":"21","author":"Harris","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cgh.2012.06.016_bib28","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.gastro.2006.12.028","article-title":"Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat","volume":"132","author":"Houdeau","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2012.06.016_bib29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nm0496-381","article-title":"Tamoxifen: teaching an old drug new tricks?","volume":"4","author":"Grainger","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.cgh.2012.06.016_bib30","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1158\/1078-0432.CCR-06-1136","article-title":"The science of selective estrogen receptor modulators: concept to clinical practice","volume":"12","author":"Jordan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cgh.2012.06.016_bib31","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.2174\/092986709788803042","article-title":"The effects of tamoxifen on immunity","volume":"16","author":"Behjati","year":"2009","journal-title":"Curr Med Chem"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356512007100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356512007100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:09:56Z","timestamp":1761541796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356512007100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1542356512007100"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2012.06.016","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Cancer Treatment on Inflammatory Bowel Disease Remission and Reactivation","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2012.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}